FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013411037> ?p ?o ?g. }

• W2013411037 endingPage "839" @default.
• W2013411037 startingPage "826" @default.
• W2013411037 abstract "Compound A ((1aR,5S,8S,10R,22aR)-5-tert-butyl-N-{(1R,2S)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[12,11-b]quinoline-8-carboxamide) is a prototype of a series of subnanomolar inhibitors of genotypes 1, 2, and 3 hepatitis C virus (HCV) NS3/4A proteases. HCV NS3/4A protease inhibitors have demonstrated high antiviral effects in patients with chronic HCV infection and are likely to form a key component of future HCV therapy.Compound A showed excellent liver exposure in rats, which is essential for compounds intended to treat HCV. The compound was mainly eliminated intact in bile and showed greater than dose proportional systemic exposure in rats. Compound A demonstrated time- and temperature-dependent uptake into rat and human hepatocytes and proved to be a substrate for rat hepatic uptake transporter Oatp1b2 and for human hepatic uptake transporters OATP1B1 and OATP1B3. The liver selectivity observed for this compound is likely to be due to transporter-mediated hepatic uptake together with moderate passive permeability.Metabolism was mainly CYP3A-mediated and generated a reactive epoxide on the vinylcyclopropyl sulfonamide moiety that could be quenched by glutathione. Similar metabolic profiles of Compound A were obtained in liver microsomes of rats and humans. The oral bioavailability at 5 mg/kg was low due to extensive hepatic first-pass effect but clearly the intestinal absorption was enough to deliver a high amount of the compound to the liver. The metabolism and disposition properties of Compound A are particularly attractive to support its evaluation as a drug candidate for the treatment of hepatitis C." @default.
• W2013411037 created "2016-06-24" @default.
• W2013411037 creator A5018868164 @default.
• W2013411037 creator A5022667959 @default.
• W2013411037 creator A5027914044 @default.
• W2013411037 creator A5033679363 @default.
• W2013411037 creator A5036851868 @default.
• W2013411037 creator A5044099332 @default.
• W2013411037 creator A5047090164 @default.
• W2013411037 creator A5054699653 @default.
• W2013411037 creator A5060422552 @default.
• W2013411037 creator A5064222916 @default.
• W2013411037 creator A5075397807 @default.
• W2013411037 creator A5076006178 @default.
• W2013411037 creator A5082048814 @default.
• W2013411037 date "2010-10-07" @default.
• W2013411037 modified "2023-09-29" @default.
• W2013411037 title "The metabolism and disposition of a potent inhibitor of hepatitis C virus NS3/4A protease" @default.
• W2013411037 cites W1965813400 @default.
• W2013411037 cites W1966043736 @default.
• W2013411037 cites W1986308869 @default.
• W2013411037 cites W1995778111 @default.
• W2013411037 cites W2001138984 @default.
• W2013411037 cites W2022057836 @default.
• W2013411037 cites W2027545702 @default.
• W2013411037 cites W2029323175 @default.
• W2013411037 cites W2036520108 @default.
• W2013411037 cites W2047208492 @default.
• W2013411037 cites W2062395204 @default.
• W2013411037 cites W2072029488 @default.
• W2013411037 cites W2077103006 @default.
• W2013411037 cites W2084553493 @default.
• W2013411037 cites W2085587542 @default.
• W2013411037 cites W2091026598 @default.
• W2013411037 cites W2092910855 @default.
• W2013411037 cites W2097729035 @default.
• W2013411037 cites W2106791445 @default.
• W2013411037 cites W2107713887 @default.
• W2013411037 cites W2108836992 @default.
• W2013411037 cites W2112876622 @default.
• W2013411037 cites W2115151001 @default.
• W2013411037 cites W2127685726 @default.
• W2013411037 cites W2140231399 @default.
• W2013411037 cites W2140369033 @default.
• W2013411037 cites W2142234431 @default.
• W2013411037 cites W2142684817 @default.
• W2013411037 cites W2148917087 @default.
• W2013411037 cites W2154155208 @default.
• W2013411037 cites W2317554121 @default.
• W2013411037 doi "https://doi.org/10.3109/00498254.2010.519061" @default.
• W2013411037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20925584" @default.
• W2013411037 hasPublicationYear "2010" @default.
• W2013411037 type Work @default.
• W2013411037 sameAs 2013411037 @default.
• W2013411037 citedByCount "16" @default.
• W2013411037 countsByYear W20134110372012 @default.
• W2013411037 countsByYear W20134110372013 @default.
• W2013411037 countsByYear W20134110372014 @default.
• W2013411037 countsByYear W20134110372015 @default.
• W2013411037 countsByYear W20134110372016 @default.
• W2013411037 countsByYear W20134110372017 @default.
• W2013411037 countsByYear W20134110372018 @default.
• W2013411037 countsByYear W20134110372019 @default.
• W2013411037 crossrefType "journal-article" @default.
• W2013411037 hasAuthorship W2013411037A5018868164 @default.
• W2013411037 hasAuthorship W2013411037A5022667959 @default.
• W2013411037 hasAuthorship W2013411037A5027914044 @default.
• W2013411037 hasAuthorship W2013411037A5033679363 @default.
• W2013411037 hasAuthorship W2013411037A5036851868 @default.
• W2013411037 hasAuthorship W2013411037A5044099332 @default.
• W2013411037 hasAuthorship W2013411037A5047090164 @default.
• W2013411037 hasAuthorship W2013411037A5054699653 @default.
• W2013411037 hasAuthorship W2013411037A5060422552 @default.
• W2013411037 hasAuthorship W2013411037A5064222916 @default.
• W2013411037 hasAuthorship W2013411037A5075397807 @default.
• W2013411037 hasAuthorship W2013411037A5076006178 @default.
• W2013411037 hasAuthorship W2013411037A5082048814 @default.
• W2013411037 hasConcept C112705442 @default.
• W2013411037 hasConcept C132379496 @default.
• W2013411037 hasConcept C142462285 @default.
• W2013411037 hasConcept C159047783 @default.
• W2013411037 hasConcept C181199279 @default.
• W2013411037 hasConcept C181389837 @default.
• W2013411037 hasConcept C185592680 @default.
• W2013411037 hasConcept C2522874641 @default.
• W2013411037 hasConcept C2776408679 @default.
• W2013411037 hasConcept C2776714187 @default.
• W2013411037 hasConcept C2781143361 @default.
• W2013411037 hasConcept C2993143319 @default.
• W2013411037 hasConcept C55493867 @default.
• W2013411037 hasConcept C62231903 @default.
• W2013411037 hasConcept C86803240 @default.
• W2013411037 hasConcept C87644729 @default.
• W2013411037 hasConcept C98274493 @default.
• W2013411037 hasConceptScore W2013411037C112705442 @default.
• W2013411037 hasConceptScore W2013411037C132379496 @default.
• W2013411037 hasConceptScore W2013411037C142462285 @default.
• W2013411037 hasConceptScore W2013411037C159047783 @default.

• next